|
This week Stand Up To Cancer scientists, advisors, patient advocates, collaborators, and donors from the US, Canada and beyond gathered together to collaborate and inspire one another in Stand Up To Cancer’s mission to discover new and effective treatments quickly to save lives now.
Here are a few groundbreaking announcements from this year’s 2020 Scientific Summit:
-
An International Team on the Early Detection and Interception of Gastric Cancer will take a new approach to fight the world’s third-leading cause of cancer death – stomach (or gastric) cancer.
-
SU2C welcomed Laurie H. Glimcher, MD, CEO of Dana-Farber Cancer Institute, a distinguished scientist and influential leader in cancer research, to the SU2C Scientific Advisory Committee.
-
A first-of-its-kind initiative to increase diversity in cancer clinical trials, to reduce disparities in cancer research, and improve minority patient outcomes.
-
Two highly respected clinical investigators will come together in a novel collaboration between leaders in breast cancer research to further increase the efficacy of immune checkpoint inhibitors for breast cancer patients.
This annual event brought together more than 300 of today’s brightest minds to share their findings, and explore how the discoveries made studying one disease can be applied to help patients with other types of cancer.
The most exciting part of this annual summit? The hope this research brings to patients who need it most. Learn more about the Stand Up To Cancer research focused on saving lives,
here.
|
